Akin Gump Team Scores $20 Million Verdict in Patent Infringement Case

(Philadelphia) – Yesterday, following a week-long trial, a Delaware federal jury awarded Boston Scientific Corp. $20 million, finding that Nevro Corp. willfully infringed multiple Boston Scientific patent claims covering spinal cord therapy technology. A team from Akin Gump led the representation of Boston Scientific in the case.

The verdict is the culmination of nearly five years of litigation related to leads used in spinal cord stimulation systems for treating chronic pain. A copy of the verdict may be found here.

Akin Gump intellectual property practice leader Steve Maslowski led the team representing Boston Scientific. New York intellectual property partner Michael Kahn also played a key trial role and commented, “This is a significant and gratifying win for our client, and we were honored to play a leading role in securing this verdict on their behalf.”

Together with Mr. Maslowski and Mr. Kahn, Akin Gump intellectual property partner Rachel Elsby and counsel Caitlin Olwell presented Boston Scientific’s case to the jury with direct- and cross-examinations. The Akin Gump trial team also included intellectual property partners Matthew Pearson and Brandon Rash, counsel Jason Weil, and associates Svetlana Pavlovic, Brooks Kenyon and Megan Mahoney, along with appellate partner Julius Chen.

Akin Gump Strauss Hauer & Feld LLP is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.

# # #